64 results on '"Sanchez-Valle, Raquel"'
Search Results
2. Plasma biomarkers as prognostic markers in Alzheimer’s disease: Influence of age at onset
3. Probabilistic computer‐aided diagnosis of Alzheimer’s disease and frontotemporal dementia based on MRI and biochemical markers
4. Exploring the relationship between MRI changes and cognitive/neuropsychiatric complaints in a cohort of long COVID‐19 patients: A cross‐sectional and longitudinal study
5. Are noradrenergic and orexinergic systems contributing to sleep‐wake patterns in early and late‐onset Alzheimer’s Disease?
6. Cognitive symptoms associated with COVID‐19: neuropsychological and biochemical characterization
7. Plasma Neurofilament Light Chain predicts neuroimaging alterations and functional decline in frontotemporal dementia
8. Diagnostic performance RT‐QuIC based detection of alpha‐synuclein seeds in a clinical cohort with cognitive impairment
9. Targeted proteomic search reveals new actors in the synaptic and lysosomal dysfunction in genetic FTD, a GENFI study.
10. Comparison of the diagnostic performance of blood‐based biomarkers using two distinct commercially available assays in a prospective memory clinic cohort
11. Catalan Early Onset Dementia Network 2021 Report
12. Refinement of Neurofilament light Dynamics in CSF and Blood for familial Alzheimer’s Disease
13. Digital and plasma biomarkers for an early diagnosis of Mild Cognitive Impairment and prodromal Alzheimer’s disease
14. Diagnosis in an early‐onset dementia clinic in the period 2016‐2021 and impact of COVID‐19 pandemic
15. Association of low frequency variants with regional cortical grey matter volumes in genetic frontotemporal dementia: Results from GENFI
16. Association of low‐frequency and rare variants with cognition in genetic frontotemporal dementia: Results from GENFI
17. Pattern and implications of neurological examination findings in autosomal dominant Alzheimer disease
18. AD‐causing variants that affect PSEN1 transmembrane domains are associated with faster neurodegeneration and cognitive decline compared to those affecting cytoplasmic domains
19. Protective association of HLA‐DRB1*04 subtypes in neurodegenerative diseases implicates acetylated tau PHF6 sequences
20. Rare missense variant (R251G) on APOE counterbalances the Alzheimer’s disease risk associated with APOE‐ε4
21. Tau‐derived Locus coeruleus degeneration as a driver for sleep‐wake alterations and neuropsychiatric symptoms in early and late‐onset Alzheimer’s Disease
22. A data‐driven disease progression model of fluid biomarkers in genetic FTD
23. A cognitive composite for genetic frontotemporal dementia: GENFI‐cog
24. ALTOIDA‐iADL for the diagnosis of Mild Cognitive Impairment and early Alzheimer's disease
25. Atrophy patterns in sporadic and genetic behavioral variant frontotemporal dementia reflect brain network architecture
26. Impact of COVID‐19 pandemic in an early‐onset dementia clinic in Barcelona
27. Sex differences in the behavioral variant of frontotemporal dementia: A new window to executive and behavioral reserve
28. Agreement of amyloid PET and CSF biomarkers in a clinical cohort
29. Four years’ experience in an early‐onset dementia clinic in Barcelona
30. Evolution of clinical‐pathological correlation of early‐onset Alzheimer's disease: 1994–2009 vs 2010–2017
31. Impact of cortical and subcortical atrophy in the diagnosis and prognosis of bvFTD: A multicenter longitudinal study
32. Distinct neuropsychological presentation and progression between early‐ and late‐onset Alzheimer’s disease
33. Differential gene expression in genetic and early‐onset Alzheimer’s disease in two biological samples: Brain tissue and lymphoblastoid cell lines
34. Accelerated long‐term forgetting over six months in cognitively normal APOE ɛ4 carriers
35. Trajectory of apathy, cognition and neural correlates in the decades before symptoms in frontotemporal dementia
36. An ABCA7 partial deletion and a GRN variant in a semantic variant of primary progressive aphasia patient
37. Functional network alterations in early‐onset Alzheimer’s disease studied with resting‐state fMRI
38. The Free Cued Selective Reminding Test detects episodic memory impairment in the presymptomatic period of familial frontotemporal dementia within the GENFI cohort
39. P3-505: PRIMARY-SPECIALIZED CARE PARTNERSHIP FOR AN EARLIER DIAGNOSIS OF AD
40. P4-213: ALZHEIMER'S DISEASE PREDICTION SERVICE (ADPS): STANDARDIZING A DIGITAL BIOMARKER FOR COGNITION ASSESSMENT IN ALZHEIMER'S DISEASE CLINICAL TRIALS
41. O2-09-02: BIPHASIC TRAJECTORY OF CHANGES FOR CORTICAL THICKNESS AND CORTICAL MEAN DIFFUSIVITY IN AUTOSOMAL-DOMINANT ALZHEIMER'S DISEASE
42. O4-03-06: LONGITUDINAL ASSOCIATION BETWEEN APATHY AND COGNITIVE DECLINE IN PRE- AND POST-SYMPTOMATIC GENETIC FRONTOTEMPORAL DEMENTIA
43. P3-370: GENDER DIFFERENCES IN THE ASSOCIATION BETWEEN LONGITUDINAL BRAIN CHANGES AND BASELINE LEVELS OF CSF ALZHEIMER'S DISEASE AND GLIAL BIOMARKERS IN HEALTHY ELDERS
44. P4-210: DISENTANGLING THE RELATIONSHIP BETWEEN SYNAPTIC AND NEURODEGENERATION CEREBROSPINAL FLUID BIOMARKERS IN ALZHEIMER'S DISEASE
45. IC-02-05: GENDER DIFFERENCES IN THE ASSOCIATION BETWEEN LONGITUDINAL BRAIN CHANGES AND BASELINE LEVELS OF CSF ALZHEIMER'S DISEASE AND GLIAL BIOMARKERS IN HEALTHY ELDERS
46. P2‐262: A CEREBROSPINAL FLUID PANEL OF SYNAPTIC PROTEINS ACROSS THE ENTIRE ALZHEIMER'S DISEASE CONTINUUM
47. P2‐347: THE HIPPOCAMPAL LONGITUDINAL AXIS: RELEVANCE FOR UNDERLYING TAU AND TDP‐43 PATHOLOGY
48. P1‐146: WHOLE EXOME SEQUENCING IN PATIENTS WITH EARLY‐ONSET ALZHEIMER'S DISEASE AND FRONTOTEMPORAL DEMENTIA: MUTATION DETECTION IN CAUSAL AND RISK GENES FOR DEMENTIA
49. CORTICAL MICROSTRUCTURAL CHANGES IN FRONTOTEMPORAL LOBAR DEGENERATION: A NEW IMAGING BIOMARKER
50. [P2-410]: VISUAL AND QUANTITATIVE ASSESSMENT OF HIPPOCAMPAL ATROPHY IN EARLY ONSET ALZHEIMER's DISEASE PATIENTS
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.